Clinical studies recruiting near Largo

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the H
Phase N/A · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07545694 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Advanced Urology Institute, LLC · Pfizer · NCT07028853 First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve
NA · Epygon · NCT04775108 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Maryland Oncology Hematology, P.A · Pfizer · NCT07144280 An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract
Phase 3 · Accel Research · Neuvosyn Laboratories, LLC · NCT07747103 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · UM Capital Region Medical Center · NRG Oncology · NCT05946213 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Advanced Urology Institute (Solaris) · CG Oncology, Inc. · NCT06567743 A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Phase 3 · Research Site · AstraZeneca · NCT07205822 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente - Largo Medical Center · NRG Oncology · NCT05174169 Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Phase 2 · Advanced Urology Institute · Dendreon · NCT06134232 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente - Largo Medical Center · NRG Oncology · NCT06748222 Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Phase N/A · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06806579 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 · Accel Research Sites - St. Petersburg-Largo · Xenon Pharmaceuticals Inc. · NCT06775379 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 SELUTION 4 De Novo Small Vessel IDE Trial
NA · HCA Largo · M.A. Med Alliance S.A. · NCT05946629 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1127 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 A Phase 1/1b Study of IAM1363 in HER2 Cancers
Phase 1 · Iambic Therapeutics, Inc · NCT06253871 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Comprehensive Hematology Oncology · Pfizer · NCT07222800 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Kaiser Permanente - Largo Medical Center · NRG Oncology · NCT04852887 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Kaiser Permanente - Largo Medical Center · NRG Oncology · NCT05080673 UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
NA · University of Maryland Capital Region Medical Center · University of Maryland, Baltimore · NCT06779617 DSLT for Reducing Medication in Glaucoma
Phase N/A · The Eye Institute of West Florida · The Eye Institute of West Florida · NCT07390890 MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
NA · University of Maryland Capital Region Health · University of Southern California · NCT07244211 An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants W
Phase 2 · Shettle Eye Research, Inc. · Dompé Farmaceutici S.p.A · NCT07503886 The CONFORM Pivotal Trial
NA · Largo Medical Center · Conformal Medical, Inc · NCT05147792 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · Comprehensive Hematology Oncology - Largo Clinic · OSE Immunotherapeutics · NCT06472245 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Kaiser Permanente - Largo Medical Center · SWOG Cancer Research Network · NCT06616584 TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
NA · Largo Medical Center · P+F Products + Features USA Inc. · NCT06137807 LANDMARK Trial: a Randomised Controlled Trial of Myval THV
NA · Meril Life Sciences Pvt. Ltd. · NCT04275726 Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Phase 3 · Baxis Site 37 · Baxis Pharmaceuticals, Inc. · NCT06911424

Look up another city

Look up another condition